Retraction notice to "Evaluation of the treatment strategies on patient-derived xenograft mice of human breast tumor" [Eur. J. Pharmacol. 889 (2020) 173605
| Errataetall: |
RetractionOf: Eur J Pharmacol. 2020 Dec 15;889:173605. - PMID 32980347 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:969 |
|---|---|
| Enthalten in: |
European journal of pharmacology - 969(2024) vom: 15. März, Seite 176350 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khalighfard, Solmaz [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 21.03.2024 published: Print-Electronic RetractionOf: Eur J Pharmacol. 2020 Dec 15;889:173605. - PMID 32980347 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.ejphar.2024.176350 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369486714 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369486714 | ||
| 003 | DE-627 | ||
| 005 | 20240322000514.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240309s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejphar.2024.176350 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1339.xml |
| 035 | |a (DE-627)NLM369486714 | ||
| 035 | |a (NLM)38458940 | ||
| 035 | |a (PII)S0014-2999(24)00038-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khalighfard, Solmaz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retraction notice to "Evaluation of the treatment strategies on patient-derived xenograft mice of human breast tumor" [Eur. J. Pharmacol. 889 (2020) 173605 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a RetractionOf: Eur J Pharmacol. 2020 Dec 15;889:173605. - PMID 32980347 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Retraction of Publication | |
| 700 | 1 | |a Alizadeh, Ali Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Poorkhani, Amirhoushang |e verfasserin |4 aut | |
| 700 | 1 | |a Motahari, Mohammadmehdi |e verfasserin |4 aut | |
| 700 | 1 | |a Tahmasebifar, Arash |e verfasserin |4 aut | |
| 700 | 1 | |a Omranipour, Ramesh |e verfasserin |4 aut | |
| 700 | 1 | |a Keshavarz, Pedram |e verfasserin |4 aut | |
| 700 | 1 | |a Haddad, Peiman |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of pharmacology |d 1967 |g 969(2024) vom: 15. März, Seite 176350 |w (DE-627)NLM000029769 |x 1879-0712 |7 nnns |
| 773 | 1 | 8 | |g volume:969 |g year:2024 |g day:15 |g month:03 |g pages:176350 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejphar.2024.176350 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 969 |j 2024 |b 15 |c 03 |h 176350 | ||